Type 1 diabetes mellitus and autoimmune cerebellar ataxia with anti-glutamate decarboxylase
Original title: Diabetes mellitus tipo 1 de inicio tardío y ataxia cerebelosa autoinmune con anti-glutamato descarboxilasa
- Sofía Pilar Ildefonso-Najarro,
- Juan Eduardo Quiroz-Aldave,
- Guillermo Ramos-Torres,
- Alejandro Román-González,
- Jenyfer María Fuentes-Mendoza,
- Marcio Concepción-Zavaleta(corresponding author)
- Hospital Guillermo Almenara Irigoyen,
- Hospital de Apoyo Chepén,
- Universidad de Antioquia,
- Universidad Científica del Sur,
- ,
- Universidad Nacional de Trujillo
Research Output:
Contribution to journal
Article
Peer-reviewOpen access
Publication Information
Output type
Research Output:
Contribution to journal
Article
Peer-reviewOriginal language
SpanishJournal (Volume, Issue Number)
Anales de la Facultad de Medicina (Volume 85, Issue 4)Publication milestones
- Published - 2024
Publication status
Published - 2024
ISSN
1025-5583Publication IDs
- Scopus: 85211732300
Abstract
The cerebellar ataxia variant associated with antibodies against glutamic acid decarboxylase 65 (GAD-Ab) is associated with type 1 diabetes mellitus (DM). We present the case of a 63-year-old woman with cerebellar ataxia of unknown origin, who was later diagnosed with T1DM. The identification of GAD-Ab in the cerebrospinal fluid (CSF) demonstrated the association between the two conditions. Diagnosis requires demonstration of increased intrathecal synthesis of GAD-Ab. We emphasize the importance of considering GAD-Ab-associated cerebellar ataxia among the causes of cerebellar ataxia to provide timely and effective treatment.
Access to documents
Sustainable Development Goals
- SDG 3 Good Health and Well
